Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Products: Biologics, Biosimilars and Interchangeables01:28

Drug Products: Biologics, Biosimilars and Interchangeables

Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

What do health insurance deductibles do to health care spending growth?

International journal of health economics and management·2026
Same author

Methods for measuring implementation fidelity to the transitional care model.

Trials·2026
Same author

Pharmaceutical Pricing and R&D as a Global Public Good.

Health economics·2026
Same author

Does hospital consolidation promote quality?: Organizational and strategic issues.

Health care management review·2025
Same author

Hospital consolidation and quality: Opening the behavioral black box.

Social science & medicine (1982)·2025
Same author

Substantial variation among Medicare beneficiaries in the impact from 2025 Part D out of pocket spending caps.

Health affairs scholar·2025

Related Experiment Video

Updated: Jun 28, 2026

Laparoscopic Left Lateral Sectionectomy: Guided by the Ligamentum Teres Hepatis and the Umbilical Fissure Vein
03:33

Laparoscopic Left Lateral Sectionectomy: Guided by the Ligamentum Teres Hepatis and the Umbilical Fissure Vein

Published on: September 27, 2024

Price transparency for medical devices.

Mark V Pauly1, Lawton R Burns

  • 1Wharton School, University of Pennsylvania, in Philadelphia, USA.

Health Affairs (Project Hope)
|November 11, 2008
PubMed
Summary

Manufacturers use price discrimination for medical devices, influenced by hospital-physician relationships. Price transparency could improve hospital negotiations and restructure these dynamics.

Area of Science:

  • Health economics
  • Medical device market analysis
  • Healthcare policy

Background:

  • Medical device manufacturers possess market power and sell differentiated products.
  • Hospital purchasing decisions are significantly influenced by medical staff.
  • Secrecy surrounding medical device transaction prices is common, despite policy proposals for greater transparency.

Purpose of the Study:

  • To explore the reasons behind manufacturers charging different prices to different hospitals for medical devices.
  • To analyze the role of price secrecy in the medical device market.
  • To evaluate the consequences of price secrecy versus disclosure on market dynamics and hospital bargaining power.

Main Methods:

  • Economic analysis of pricing strategies in the medical device market.

More Related Videos

Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy
07:10

Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy

Published on: June 18, 2020

Improvement of a Closed Chest Porcine Myocardial Infarction Model by Standardization of Tissue and Blood Sampling Procedures
10:01

Improvement of a Closed Chest Porcine Myocardial Infarction Model by Standardization of Tissue and Blood Sampling Procedures

Published on: March 12, 2018

Related Experiment Videos

Last Updated: Jun 28, 2026

Laparoscopic Left Lateral Sectionectomy: Guided by the Ligamentum Teres Hepatis and the Umbilical Fissure Vein
03:33

Laparoscopic Left Lateral Sectionectomy: Guided by the Ligamentum Teres Hepatis and the Umbilical Fissure Vein

Published on: September 27, 2024

Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy
07:10

Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy

Published on: June 18, 2020

Improvement of a Closed Chest Porcine Myocardial Infarction Model by Standardization of Tissue and Blood Sampling Procedures
10:01

Improvement of a Closed Chest Porcine Myocardial Infarction Model by Standardization of Tissue and Blood Sampling Procedures

Published on: March 12, 2018

  • Discussion of the influence of hospital-physician relationships on purchasing decisions.
  • Examination of the potential impacts of price transparency legislation.

    • Main Results:

    • Manufacturer price discrimination is linked to hospital-physician relationships.
    • Secrecy allows manufacturers to leverage these relationships for pricing advantages.
    • Price disclosure can lead to a restructuring of hospital-physician dynamics.

    Conclusions:

    • Hospital-physician relationships are central to understanding medical device pricing and manufacturer gains from price discrimination.
    • Mandating price disclosure can empower hospitals by altering these relationships and improving their bargaining position.
    • Increased transparency in medical device pricing can foster a more equitable market.